nodes	percent_of_prediction	percent_of_DWPC	metapath
Magnesium salicylate—ALB—hematologic cancer	0.192	1	CbGaD
Magnesium salicylate—PTGS2—Lenalidomide—hematologic cancer	0.0971	0.181	CbGbCtD
Magnesium salicylate—PTGS2—Thalidomide—hematologic cancer	0.0518	0.0965	CbGbCtD
Magnesium salicylate—PTGS1—Bortezomib—hematologic cancer	0.0503	0.0935	CbGbCtD
Magnesium salicylate—PTGS1—Thalidomide—hematologic cancer	0.0438	0.0815	CbGbCtD
Magnesium salicylate—PTGS1—Ifosfamide—hematologic cancer	0.0385	0.0717	CbGbCtD
Magnesium salicylate—PTGS1—Imatinib—hematologic cancer	0.0368	0.0685	CbGbCtD
Magnesium salicylate—PTGS2—Triamcinolone—hematologic cancer	0.0359	0.0669	CbGbCtD
Magnesium salicylate—PTGS2—Betamethasone—hematologic cancer	0.0308	0.0574	CbGbCtD
Magnesium salicylate—ALB—Imatinib—hematologic cancer	0.0275	0.0512	CbGbCtD
Magnesium salicylate—PTGS2—Cisplatin—hematologic cancer	0.0222	0.0413	CbGbCtD
Magnesium salicylate—PTGS2—Etoposide—hematologic cancer	0.0218	0.0406	CbGbCtD
Magnesium salicylate—PTGS1—Etoposide—hematologic cancer	0.0184	0.0343	CbGbCtD
Magnesium salicylate—ALB—Prednisone—hematologic cancer	0.0181	0.0337	CbGbCtD
Magnesium salicylate—PTGS2—Dexamethasone—hematologic cancer	0.0179	0.0334	CbGbCtD
Magnesium salicylate—ALB—Irinotecan—hematologic cancer	0.0172	0.032	CbGbCtD
Magnesium salicylate—ALB—Methotrexate—hematologic cancer	0.00909	0.0169	CbGbCtD
Magnesium salicylate—PTGS2—ovarian follicle—hematologic cancer	0.00432	0.498	CbGeAlD
Magnesium salicylate—Olsalazine—IFNG—hematologic cancer	0.0011	0.444	CrCbGaD
Magnesium salicylate—Olsalazine—ALOX5—hematologic cancer	0.000904	0.366	CrCbGaD
Magnesium salicylate—PTGS1—hematopoietic system—hematologic cancer	0.000546	0.0629	CbGeAlD
Magnesium salicylate—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000543	0.209	CbGdCrCtD
Magnesium salicylate—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000543	0.209	CbGdCrCtD
Magnesium salicylate—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.000531	0.205	CbGdCrCtD
Magnesium salicylate—ALB—testis—hematologic cancer	0.000525	0.0605	CbGeAlD
Magnesium salicylate—PTGS2—hematopoietic system—hematologic cancer	0.000522	0.0601	CbGeAlD
Magnesium salicylate—ALB—lymph node—hematologic cancer	0.000381	0.0438	CbGeAlD
Magnesium salicylate—PTGS1—blood—hematologic cancer	0.000362	0.0417	CbGeAlD
Magnesium salicylate—PTGS2—blood—hematologic cancer	0.000346	0.0398	CbGeAlD
Magnesium salicylate—PTGS2—bone marrow—hematologic cancer	0.000335	0.0385	CbGeAlD
Magnesium salicylate—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	0.000328	0.126	CbGdCrCtD
Magnesium salicylate—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.000328	0.126	CbGdCrCtD
Magnesium salicylate—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.00032	0.124	CbGdCrCtD
Magnesium salicylate—PTGS1—lung—hematologic cancer	0.000317	0.0365	CbGeAlD
Magnesium salicylate—PTGS2—lung—hematologic cancer	0.000303	0.0349	CbGeAlD
Magnesium salicylate—PTGS1—testis—hematologic cancer	0.000299	0.0345	CbGeAlD
Magnesium salicylate—PTGS1—lymph node—hematologic cancer	0.000217	0.025	CbGeAlD
Magnesium salicylate—PTGS2—lymph node—hematologic cancer	0.000207	0.0239	CbGeAlD
Magnesium salicylate—Oxcarbazepine—ALB—hematologic cancer	0.000115	0.0464	CrCbGaD
Magnesium salicylate—Salicylic acid—ALB—hematologic cancer	0.000102	0.0412	CrCbGaD
Magnesium salicylate—Salicylic acid—ABCB1—hematologic cancer	9.72e-05	0.0393	CrCbGaD
Magnesium salicylate—Ketoprofen—ALB—hematologic cancer	8.07e-05	0.0327	CrCbGaD
Magnesium salicylate—Carbamazepine—ABCB1—hematologic cancer	7.46e-05	0.0302	CrCbGaD
Magnesium salicylate—Rash—Vinorelbine—hematologic cancer	7.45e-05	0.000388	CcSEcCtD
Magnesium salicylate—Dermatitis—Vinorelbine—hematologic cancer	7.44e-05	0.000388	CcSEcCtD
Magnesium salicylate—Headache—Vinorelbine—hematologic cancer	7.4e-05	0.000386	CcSEcCtD
Magnesium salicylate—Asthma—Doxorubicin—hematologic cancer	7.39e-05	0.000385	CcSEcCtD
Magnesium salicylate—Oedema—Triamcinolone—hematologic cancer	7.35e-05	0.000383	CcSEcCtD
Magnesium salicylate—Pruritus—Alitretinoin—hematologic cancer	7.34e-05	0.000383	CcSEcCtD
Magnesium salicylate—Sweating—Methotrexate—hematologic cancer	7.3e-05	0.00038	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Cisplatin—hematologic cancer	7.29e-05	0.00038	CcSEcCtD
Magnesium salicylate—Weight increased—Epirubicin—hematologic cancer	7.27e-05	0.000379	CcSEcCtD
Magnesium salicylate—Pruritus—Ifosfamide—hematologic cancer	7.26e-05	0.000378	CcSEcCtD
Magnesium salicylate—Shock—Triamcinolone—hematologic cancer	7.23e-05	0.000377	CcSEcCtD
Magnesium salicylate—Dizziness—Thalidomide—hematologic cancer	7.22e-05	0.000376	CcSEcCtD
Magnesium salicylate—Somnolence—Etoposide—hematologic cancer	7.2e-05	0.000375	CcSEcCtD
Magnesium salicylate—Nausea—Bortezomib—hematologic cancer	7.19e-05	0.000375	CcSEcCtD
Magnesium salicylate—Epistaxis—Methotrexate—hematologic cancer	7.18e-05	0.000374	CcSEcCtD
Magnesium salicylate—Vomiting—Thiotepa—hematologic cancer	7.17e-05	0.000374	CcSEcCtD
Magnesium salicylate—Diarrhoea—Carmustine—hematologic cancer	7.17e-05	0.000374	CcSEcCtD
Magnesium salicylate—Nausea—Bleomycin—hematologic cancer	7.13e-05	0.000372	CcSEcCtD
Magnesium salicylate—Drowsiness—Epirubicin—hematologic cancer	7.12e-05	0.000371	CcSEcCtD
Magnesium salicylate—Erythema—Prednisone—hematologic cancer	7.12e-05	0.000371	CcSEcCtD
Magnesium salicylate—Rash—Thiotepa—hematologic cancer	7.11e-05	0.000371	CcSEcCtD
Magnesium salicylate—Dermatitis—Thiotepa—hematologic cancer	7.11e-05	0.00037	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Triamcinolone—hematologic cancer	7.11e-05	0.00037	CcSEcCtD
Magnesium salicylate—Diarrhoea—Alitretinoin—hematologic cancer	7.1e-05	0.00037	CcSEcCtD
Magnesium salicylate—Headache—Thiotepa—hematologic cancer	7.07e-05	0.000368	CcSEcCtD
Magnesium salicylate—Decreased appetite—Etoposide—hematologic cancer	7.04e-05	0.000367	CcSEcCtD
Magnesium salicylate—Diarrhoea—Ifosfamide—hematologic cancer	7.02e-05	0.000366	CcSEcCtD
Magnesium salicylate—Nausea—Vinorelbine—hematologic cancer	7.02e-05	0.000366	CcSEcCtD
Magnesium salicylate—Vomiting—Thalidomide—hematologic cancer	6.94e-05	0.000362	CcSEcCtD
Magnesium salicylate—Dizziness—Carmustine—hematologic cancer	6.93e-05	0.000361	CcSEcCtD
Magnesium salicylate—Pain—Etoposide—hematologic cancer	6.93e-05	0.000361	CcSEcCtD
Magnesium salicylate—Constipation—Etoposide—hematologic cancer	6.93e-05	0.000361	CcSEcCtD
Magnesium salicylate—Rash—Thalidomide—hematologic cancer	6.88e-05	0.000359	CcSEcCtD
Magnesium salicylate—Dermatitis—Thalidomide—hematologic cancer	6.87e-05	0.000358	CcSEcCtD
Magnesium salicylate—Dizziness—Alitretinoin—hematologic cancer	6.86e-05	0.000358	CcSEcCtD
Magnesium salicylate—Diarrhoea—Vincristine—hematologic cancer	6.84e-05	0.000357	CcSEcCtD
Magnesium salicylate—Headache—Thalidomide—hematologic cancer	6.84e-05	0.000356	CcSEcCtD
Magnesium salicylate—Pain—Prednisolone—hematologic cancer	6.83e-05	0.000356	CcSEcCtD
Magnesium salicylate—Hepatitis—Methotrexate—hematologic cancer	6.83e-05	0.000356	CcSEcCtD
Magnesium salicylate—Sweating—Epirubicin—hematologic cancer	6.83e-05	0.000356	CcSEcCtD
Magnesium salicylate—Dizziness—Ifosfamide—hematologic cancer	6.78e-05	0.000354	CcSEcCtD
Magnesium salicylate—Weight increased—Doxorubicin—hematologic cancer	6.73e-05	0.000351	CcSEcCtD
Magnesium salicylate—Epistaxis—Epirubicin—hematologic cancer	6.72e-05	0.00035	CcSEcCtD
Magnesium salicylate—Pruritus—Gemcitabine—hematologic cancer	6.71e-05	0.00035	CcSEcCtD
Magnesium salicylate—Nausea—Thiotepa—hematologic cancer	6.7e-05	0.000349	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Etoposide—hematologic cancer	6.68e-05	0.000348	CcSEcCtD
Magnesium salicylate—Oedema—Betamethasone—hematologic cancer	6.67e-05	0.000348	CcSEcCtD
Magnesium salicylate—Oedema—Dexamethasone—hematologic cancer	6.67e-05	0.000348	CcSEcCtD
Magnesium salicylate—Diarrhoea—Mitoxantrone—hematologic cancer	6.67e-05	0.000347	CcSEcCtD
Magnesium salicylate—Diarrhoea—Irinotecan—hematologic cancer	6.67e-05	0.000347	CcSEcCtD
Magnesium salicylate—Vomiting—Carmustine—hematologic cancer	6.66e-05	0.000347	CcSEcCtD
Magnesium salicylate—Dizziness—Vincristine—hematologic cancer	6.61e-05	0.000345	CcSEcCtD
Magnesium salicylate—Rash—Carmustine—hematologic cancer	6.61e-05	0.000344	CcSEcCtD
Magnesium salicylate—Dermatitis—Carmustine—hematologic cancer	6.6e-05	0.000344	CcSEcCtD
Magnesium salicylate—Vomiting—Alitretinoin—hematologic cancer	6.6e-05	0.000344	CcSEcCtD
Magnesium salicylate—Drowsiness—Doxorubicin—hematologic cancer	6.59e-05	0.000343	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Prednisolone—hematologic cancer	6.59e-05	0.000343	CcSEcCtD
Magnesium salicylate—Headache—Carmustine—hematologic cancer	6.56e-05	0.000342	CcSEcCtD
Magnesium salicylate—Shock—Betamethasone—hematologic cancer	6.56e-05	0.000342	CcSEcCtD
Magnesium salicylate—Shock—Dexamethasone—hematologic cancer	6.56e-05	0.000342	CcSEcCtD
Magnesium salicylate—Rash—Alitretinoin—hematologic cancer	6.55e-05	0.000341	CcSEcCtD
Magnesium salicylate—Dermatitis—Alitretinoin—hematologic cancer	6.54e-05	0.000341	CcSEcCtD
Magnesium salicylate—Vomiting—Ifosfamide—hematologic cancer	6.52e-05	0.00034	CcSEcCtD
Magnesium salicylate—Headache—Alitretinoin—hematologic cancer	6.5e-05	0.000339	CcSEcCtD
Magnesium salicylate—Diarrhoea—Gemcitabine—hematologic cancer	6.49e-05	0.000338	CcSEcCtD
Magnesium salicylate—Nausea—Thalidomide—hematologic cancer	6.48e-05	0.000338	CcSEcCtD
Magnesium salicylate—Dyspepsia—Triamcinolone—hematologic cancer	6.47e-05	0.000337	CcSEcCtD
Magnesium salicylate—Rash—Ifosfamide—hematologic cancer	6.47e-05	0.000337	CcSEcCtD
Magnesium salicylate—Dermatitis—Ifosfamide—hematologic cancer	6.46e-05	0.000337	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Methotrexate—hematologic cancer	6.46e-05	0.000337	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Betamethasone—hematologic cancer	6.45e-05	0.000336	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Dexamethasone—hematologic cancer	6.45e-05	0.000336	CcSEcCtD
Magnesium salicylate—Dizziness—Irinotecan—hematologic cancer	6.44e-05	0.000336	CcSEcCtD
Magnesium salicylate—Urticaria—Etoposide—hematologic cancer	6.44e-05	0.000336	CcSEcCtD
Magnesium salicylate—Hepatitis—Epirubicin—hematologic cancer	6.39e-05	0.000333	CcSEcCtD
Magnesium salicylate—Tinnitus—Methotrexate—hematologic cancer	6.37e-05	0.000332	CcSEcCtD
Magnesium salicylate—Vomiting—Vincristine—hematologic cancer	6.36e-05	0.000331	CcSEcCtD
Magnesium salicylate—Anorexia—Dexamethasone—hematologic cancer	6.36e-05	0.000331	CcSEcCtD
Magnesium salicylate—Anorexia—Betamethasone—hematologic cancer	6.36e-05	0.000331	CcSEcCtD
Magnesium salicylate—Urticaria—Prednisolone—hematologic cancer	6.35e-05	0.000331	CcSEcCtD
Magnesium salicylate—Sweating—Doxorubicin—hematologic cancer	6.32e-05	0.000329	CcSEcCtD
Magnesium salicylate—Rash—Vincristine—hematologic cancer	6.31e-05	0.000329	CcSEcCtD
Magnesium salicylate—Dermatitis—Vincristine—hematologic cancer	6.3e-05	0.000328	CcSEcCtD
Magnesium salicylate—Pain—Triamcinolone—hematologic cancer	6.29e-05	0.000328	CcSEcCtD
Magnesium salicylate—Headache—Vincristine—hematologic cancer	6.27e-05	0.000327	CcSEcCtD
Magnesium salicylate—Hypotension—Dexamethasone—hematologic cancer	6.23e-05	0.000325	CcSEcCtD
Magnesium salicylate—Hypotension—Betamethasone—hematologic cancer	6.23e-05	0.000325	CcSEcCtD
Magnesium salicylate—Nausea—Carmustine—hematologic cancer	6.22e-05	0.000324	CcSEcCtD
Magnesium salicylate—Epistaxis—Doxorubicin—hematologic cancer	6.22e-05	0.000324	CcSEcCtD
Magnesium salicylate—Vomiting—Mitoxantrone—hematologic cancer	6.19e-05	0.000323	CcSEcCtD
Magnesium salicylate—Vomiting—Irinotecan—hematologic cancer	6.19e-05	0.000323	CcSEcCtD
Magnesium salicylate—Nausea—Alitretinoin—hematologic cancer	6.17e-05	0.000321	CcSEcCtD
Magnesium salicylate—Rash—Mitoxantrone—hematologic cancer	6.14e-05	0.00032	CcSEcCtD
Magnesium salicylate—Rash—Irinotecan—hematologic cancer	6.14e-05	0.00032	CcSEcCtD
Magnesium salicylate—Dermatitis—Mitoxantrone—hematologic cancer	6.14e-05	0.00032	CcSEcCtD
Magnesium salicylate—Dermatitis—Irinotecan—hematologic cancer	6.14e-05	0.00032	CcSEcCtD
Magnesium salicylate—Headache—Mitoxantrone—hematologic cancer	6.1e-05	0.000318	CcSEcCtD
Magnesium salicylate—Headache—Irinotecan—hematologic cancer	6.1e-05	0.000318	CcSEcCtD
Magnesium salicylate—Nausea—Ifosfamide—hematologic cancer	6.09e-05	0.000318	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Triamcinolone—hematologic cancer	6.06e-05	0.000316	CcSEcCtD
Magnesium salicylate—Diarrhoea—Cisplatin—hematologic cancer	6.05e-05	0.000315	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Epirubicin—hematologic cancer	6.05e-05	0.000315	CcSEcCtD
Magnesium salicylate—Vomiting—Gemcitabine—hematologic cancer	6.03e-05	0.000314	CcSEcCtD
Magnesium salicylate—Rash—Gemcitabine—hematologic cancer	5.98e-05	0.000312	CcSEcCtD
Magnesium salicylate—Dermatitis—Gemcitabine—hematologic cancer	5.98e-05	0.000312	CcSEcCtD
Magnesium salicylate—Tinnitus—Epirubicin—hematologic cancer	5.96e-05	0.000311	CcSEcCtD
Magnesium salicylate—Erythema—Methotrexate—hematologic cancer	5.95e-05	0.00031	CcSEcCtD
Magnesium salicylate—Headache—Gemcitabine—hematologic cancer	5.94e-05	0.00031	CcSEcCtD
Magnesium salicylate—Nausea—Vincristine—hematologic cancer	5.94e-05	0.00031	CcSEcCtD
Magnesium salicylate—Flushing—Epirubicin—hematologic cancer	5.93e-05	0.000309	CcSEcCtD
Magnesium salicylate—Hepatitis—Doxorubicin—hematologic cancer	5.92e-05	0.000308	CcSEcCtD
Magnesium salicylate—Dyspepsia—Dexamethasone—hematologic cancer	5.87e-05	0.000306	CcSEcCtD
Magnesium salicylate—Dyspepsia—Betamethasone—hematologic cancer	5.87e-05	0.000306	CcSEcCtD
Magnesium salicylate—Urticaria—Triamcinolone—hematologic cancer	5.84e-05	0.000304	CcSEcCtD
Magnesium salicylate—Dysgeusia—Methotrexate—hematologic cancer	5.82e-05	0.000304	CcSEcCtD
Magnesium salicylate—Oedema—Prednisone—hematologic cancer	5.81e-05	0.000303	CcSEcCtD
Magnesium salicylate—Decreased appetite—Betamethasone—hematologic cancer	5.8e-05	0.000302	CcSEcCtD
Magnesium salicylate—Decreased appetite—Dexamethasone—hematologic cancer	5.8e-05	0.000302	CcSEcCtD
Magnesium salicylate—Nausea—Mitoxantrone—hematologic cancer	5.79e-05	0.000302	CcSEcCtD
Magnesium salicylate—Nausea—Irinotecan—hematologic cancer	5.79e-05	0.000302	CcSEcCtD
Magnesium salicylate—Pruritus—Etoposide—hematologic cancer	5.73e-05	0.000299	CcSEcCtD
Magnesium salicylate—Shock—Prednisone—hematologic cancer	5.71e-05	0.000298	CcSEcCtD
Magnesium salicylate—Pain—Dexamethasone—hematologic cancer	5.7e-05	0.000297	CcSEcCtD
Magnesium salicylate—Pain—Betamethasone—hematologic cancer	5.7e-05	0.000297	CcSEcCtD
Magnesium salicylate—Nausea—Gemcitabine—hematologic cancer	5.64e-05	0.000294	CcSEcCtD
Magnesium salicylate—Vomiting—Cisplatin—hematologic cancer	5.62e-05	0.000293	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Prednisone—hematologic cancer	5.61e-05	0.000293	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Doxorubicin—hematologic cancer	5.59e-05	0.000292	CcSEcCtD
Magnesium salicylate—Rash—Cisplatin—hematologic cancer	5.58e-05	0.000291	CcSEcCtD
Magnesium salicylate—Dermatitis—Cisplatin—hematologic cancer	5.57e-05	0.00029	CcSEcCtD
Magnesium salicylate—Erythema—Epirubicin—hematologic cancer	5.57e-05	0.00029	CcSEcCtD
Magnesium salicylate—Diarrhoea—Etoposide—hematologic cancer	5.54e-05	0.000289	CcSEcCtD
Magnesium salicylate—Anorexia—Prednisone—hematologic cancer	5.54e-05	0.000289	CcSEcCtD
Magnesium salicylate—Tinnitus—Doxorubicin—hematologic cancer	5.52e-05	0.000287	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Dexamethasone—hematologic cancer	5.5e-05	0.000286	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Betamethasone—hematologic cancer	5.5e-05	0.000286	CcSEcCtD
Magnesium salicylate—Flushing—Doxorubicin—hematologic cancer	5.49e-05	0.000286	CcSEcCtD
Magnesium salicylate—Dysgeusia—Epirubicin—hematologic cancer	5.45e-05	0.000284	CcSEcCtD
Magnesium salicylate—Dizziness—Etoposide—hematologic cancer	5.36e-05	0.000279	CcSEcCtD
Magnesium salicylate—Urticaria—Dexamethasone—hematologic cancer	5.3e-05	0.000276	CcSEcCtD
Magnesium salicylate—Urticaria—Betamethasone—hematologic cancer	5.3e-05	0.000276	CcSEcCtD
Magnesium salicylate—Dizziness—Prednisolone—hematologic cancer	5.29e-05	0.000275	CcSEcCtD
Magnesium salicylate—Nausea—Cisplatin—hematologic cancer	5.25e-05	0.000274	CcSEcCtD
Magnesium salicylate—Pruritus—Triamcinolone—hematologic cancer	5.2e-05	0.000271	CcSEcCtD
Magnesium salicylate—Vomiting—Etoposide—hematologic cancer	5.15e-05	0.000269	CcSEcCtD
Magnesium salicylate—Erythema—Doxorubicin—hematologic cancer	5.15e-05	0.000268	CcSEcCtD
Magnesium salicylate—Dyspepsia—Prednisone—hematologic cancer	5.11e-05	0.000266	CcSEcCtD
Magnesium salicylate—Rash—Etoposide—hematologic cancer	5.11e-05	0.000266	CcSEcCtD
Magnesium salicylate—Dermatitis—Etoposide—hematologic cancer	5.1e-05	0.000266	CcSEcCtD
Magnesium salicylate—Headache—Etoposide—hematologic cancer	5.08e-05	0.000265	CcSEcCtD
Magnesium salicylate—Decreased appetite—Prednisone—hematologic cancer	5.05e-05	0.000263	CcSEcCtD
Magnesium salicylate—Dysgeusia—Doxorubicin—hematologic cancer	5.04e-05	0.000263	CcSEcCtD
Magnesium salicylate—Rash—Prednisolone—hematologic cancer	5.04e-05	0.000263	CcSEcCtD
Magnesium salicylate—Dermatitis—Prednisolone—hematologic cancer	5.03e-05	0.000262	CcSEcCtD
Magnesium salicylate—Headache—Prednisolone—hematologic cancer	5.01e-05	0.000261	CcSEcCtD
Magnesium salicylate—Constipation—Prednisone—hematologic cancer	4.97e-05	0.000259	CcSEcCtD
Magnesium salicylate—Confusional state—Methotrexate—hematologic cancer	4.89e-05	0.000255	CcSEcCtD
Magnesium salicylate—Dizziness—Triamcinolone—hematologic cancer	4.86e-05	0.000253	CcSEcCtD
Magnesium salicylate—Nausea—Etoposide—hematologic cancer	4.81e-05	0.000251	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Prednisone—hematologic cancer	4.79e-05	0.000249	CcSEcCtD
Magnesium salicylate—Nausea—Prednisolone—hematologic cancer	4.75e-05	0.000247	CcSEcCtD
Magnesium salicylate—Pruritus—Dexamethasone—hematologic cancer	4.72e-05	0.000246	CcSEcCtD
Magnesium salicylate—Pruritus—Betamethasone—hematologic cancer	4.72e-05	0.000246	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Methotrexate—hematologic cancer	4.69e-05	0.000245	CcSEcCtD
Magnesium salicylate—Vomiting—Triamcinolone—hematologic cancer	4.67e-05	0.000244	CcSEcCtD
Magnesium salicylate—Rash—Triamcinolone—hematologic cancer	4.63e-05	0.000242	CcSEcCtD
Magnesium salicylate—Dermatitis—Triamcinolone—hematologic cancer	4.63e-05	0.000241	CcSEcCtD
Magnesium salicylate—Anorexia—Methotrexate—hematologic cancer	4.63e-05	0.000241	CcSEcCtD
Magnesium salicylate—Urticaria—Prednisone—hematologic cancer	4.61e-05	0.00024	CcSEcCtD
Magnesium salicylate—Headache—Triamcinolone—hematologic cancer	4.6e-05	0.00024	CcSEcCtD
Magnesium salicylate—Confusional state—Epirubicin—hematologic cancer	4.58e-05	0.000239	CcSEcCtD
Magnesium salicylate—Diarrhoea—Dexamethasone—hematologic cancer	4.56e-05	0.000238	CcSEcCtD
Magnesium salicylate—Diarrhoea—Betamethasone—hematologic cancer	4.56e-05	0.000238	CcSEcCtD
Magnesium salicylate—Oedema—Epirubicin—hematologic cancer	4.54e-05	0.000237	CcSEcCtD
Magnesium salicylate—Hypotension—Methotrexate—hematologic cancer	4.54e-05	0.000236	CcSEcCtD
Magnesium salicylate—Shock—Epirubicin—hematologic cancer	4.47e-05	0.000233	CcSEcCtD
Magnesium salicylate—Dizziness—Dexamethasone—hematologic cancer	4.41e-05	0.00023	CcSEcCtD
Magnesium salicylate—Dizziness—Betamethasone—hematologic cancer	4.41e-05	0.00023	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Epirubicin—hematologic cancer	4.39e-05	0.000229	CcSEcCtD
Magnesium salicylate—Nausea—Triamcinolone—hematologic cancer	4.37e-05	0.000228	CcSEcCtD
Magnesium salicylate—Anorexia—Epirubicin—hematologic cancer	4.33e-05	0.000226	CcSEcCtD
Magnesium salicylate—Somnolence—Methotrexate—hematologic cancer	4.31e-05	0.000225	CcSEcCtD
Magnesium salicylate—Dyspepsia—Methotrexate—hematologic cancer	4.27e-05	0.000223	CcSEcCtD
Magnesium salicylate—Hypotension—Epirubicin—hematologic cancer	4.24e-05	0.000221	CcSEcCtD
Magnesium salicylate—Vomiting—Dexamethasone—hematologic cancer	4.24e-05	0.000221	CcSEcCtD
Magnesium salicylate—Vomiting—Betamethasone—hematologic cancer	4.24e-05	0.000221	CcSEcCtD
Magnesium salicylate—Confusional state—Doxorubicin—hematologic cancer	4.24e-05	0.000221	CcSEcCtD
Magnesium salicylate—Decreased appetite—Methotrexate—hematologic cancer	4.22e-05	0.00022	CcSEcCtD
Magnesium salicylate—Rash—Betamethasone—hematologic cancer	4.2e-05	0.000219	CcSEcCtD
Magnesium salicylate—Rash—Dexamethasone—hematologic cancer	4.2e-05	0.000219	CcSEcCtD
Magnesium salicylate—Oedema—Doxorubicin—hematologic cancer	4.2e-05	0.000219	CcSEcCtD
Magnesium salicylate—Dermatitis—Dexamethasone—hematologic cancer	4.2e-05	0.000219	CcSEcCtD
Magnesium salicylate—Dermatitis—Betamethasone—hematologic cancer	4.2e-05	0.000219	CcSEcCtD
Magnesium salicylate—Headache—Dexamethasone—hematologic cancer	4.18e-05	0.000218	CcSEcCtD
Magnesium salicylate—Headache—Betamethasone—hematologic cancer	4.18e-05	0.000218	CcSEcCtD
Magnesium salicylate—Pain—Methotrexate—hematologic cancer	4.15e-05	0.000216	CcSEcCtD
Magnesium salicylate—Shock—Doxorubicin—hematologic cancer	4.13e-05	0.000216	CcSEcCtD
Magnesium salicylate—Pruritus—Prednisone—hematologic cancer	4.11e-05	0.000214	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Doxorubicin—hematologic cancer	4.06e-05	0.000212	CcSEcCtD
Magnesium salicylate—Somnolence—Epirubicin—hematologic cancer	4.04e-05	0.00021	CcSEcCtD
Magnesium salicylate—Anorexia—Doxorubicin—hematologic cancer	4.01e-05	0.000209	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Methotrexate—hematologic cancer	4e-05	0.000208	CcSEcCtD
Magnesium salicylate—Dyspepsia—Epirubicin—hematologic cancer	4e-05	0.000208	CcSEcCtD
Magnesium salicylate—Diarrhoea—Prednisone—hematologic cancer	3.97e-05	0.000207	CcSEcCtD
Magnesium salicylate—Nausea—Dexamethasone—hematologic cancer	3.96e-05	0.000206	CcSEcCtD
Magnesium salicylate—Nausea—Betamethasone—hematologic cancer	3.96e-05	0.000206	CcSEcCtD
Magnesium salicylate—Decreased appetite—Epirubicin—hematologic cancer	3.95e-05	0.000206	CcSEcCtD
Magnesium salicylate—Hypotension—Doxorubicin—hematologic cancer	3.93e-05	0.000205	CcSEcCtD
Magnesium salicylate—Pain—Epirubicin—hematologic cancer	3.88e-05	0.000202	CcSEcCtD
Magnesium salicylate—Constipation—Epirubicin—hematologic cancer	3.88e-05	0.000202	CcSEcCtD
Magnesium salicylate—Urticaria—Methotrexate—hematologic cancer	3.86e-05	0.000201	CcSEcCtD
Magnesium salicylate—Dizziness—Prednisone—hematologic cancer	3.84e-05	0.0002	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Epirubicin—hematologic cancer	3.74e-05	0.000195	CcSEcCtD
Magnesium salicylate—Somnolence—Doxorubicin—hematologic cancer	3.74e-05	0.000195	CcSEcCtD
Magnesium salicylate—Dyspepsia—Doxorubicin—hematologic cancer	3.7e-05	0.000193	CcSEcCtD
Magnesium salicylate—Vomiting—Prednisone—hematologic cancer	3.69e-05	0.000192	CcSEcCtD
Magnesium salicylate—Rash—Prednisone—hematologic cancer	3.66e-05	0.000191	CcSEcCtD
Magnesium salicylate—Dermatitis—Prednisone—hematologic cancer	3.66e-05	0.000191	CcSEcCtD
Magnesium salicylate—Decreased appetite—Doxorubicin—hematologic cancer	3.65e-05	0.00019	CcSEcCtD
Magnesium salicylate—Headache—Prednisone—hematologic cancer	3.64e-05	0.00019	CcSEcCtD
Magnesium salicylate—Urticaria—Epirubicin—hematologic cancer	3.61e-05	0.000188	CcSEcCtD
Magnesium salicylate—Constipation—Doxorubicin—hematologic cancer	3.59e-05	0.000187	CcSEcCtD
Magnesium salicylate—Pain—Doxorubicin—hematologic cancer	3.59e-05	0.000187	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Doxorubicin—hematologic cancer	3.46e-05	0.000181	CcSEcCtD
Magnesium salicylate—Nausea—Prednisone—hematologic cancer	3.45e-05	0.00018	CcSEcCtD
Magnesium salicylate—Pruritus—Methotrexate—hematologic cancer	3.43e-05	0.000179	CcSEcCtD
Magnesium salicylate—Urticaria—Doxorubicin—hematologic cancer	3.34e-05	0.000174	CcSEcCtD
Magnesium salicylate—Diarrhoea—Methotrexate—hematologic cancer	3.32e-05	0.000173	CcSEcCtD
Magnesium salicylate—Pruritus—Epirubicin—hematologic cancer	3.21e-05	0.000167	CcSEcCtD
Magnesium salicylate—Dizziness—Methotrexate—hematologic cancer	3.21e-05	0.000167	CcSEcCtD
Magnesium salicylate—Diarrhoea—Epirubicin—hematologic cancer	3.11e-05	0.000162	CcSEcCtD
Magnesium salicylate—Vomiting—Methotrexate—hematologic cancer	3.09e-05	0.000161	CcSEcCtD
Magnesium salicylate—Rash—Methotrexate—hematologic cancer	3.06e-05	0.00016	CcSEcCtD
Magnesium salicylate—Dermatitis—Methotrexate—hematologic cancer	3.06e-05	0.000159	CcSEcCtD
Magnesium salicylate—Headache—Methotrexate—hematologic cancer	3.04e-05	0.000158	CcSEcCtD
Magnesium salicylate—Dizziness—Epirubicin—hematologic cancer	3e-05	0.000157	CcSEcCtD
Magnesium salicylate—Pruritus—Doxorubicin—hematologic cancer	2.97e-05	0.000155	CcSEcCtD
Magnesium salicylate—Vomiting—Epirubicin—hematologic cancer	2.89e-05	0.000151	CcSEcCtD
Magnesium salicylate—Nausea—Methotrexate—hematologic cancer	2.88e-05	0.00015	CcSEcCtD
Magnesium salicylate—Diarrhoea—Doxorubicin—hematologic cancer	2.88e-05	0.00015	CcSEcCtD
Magnesium salicylate—Rash—Epirubicin—hematologic cancer	2.86e-05	0.000149	CcSEcCtD
Magnesium salicylate—Dermatitis—Epirubicin—hematologic cancer	2.86e-05	0.000149	CcSEcCtD
Magnesium salicylate—Headache—Epirubicin—hematologic cancer	2.85e-05	0.000148	CcSEcCtD
Magnesium salicylate—Dizziness—Doxorubicin—hematologic cancer	2.78e-05	0.000145	CcSEcCtD
Magnesium salicylate—Nausea—Epirubicin—hematologic cancer	2.7e-05	0.000141	CcSEcCtD
Magnesium salicylate—Vomiting—Doxorubicin—hematologic cancer	2.67e-05	0.000139	CcSEcCtD
Magnesium salicylate—Rash—Doxorubicin—hematologic cancer	2.65e-05	0.000138	CcSEcCtD
Magnesium salicylate—Dermatitis—Doxorubicin—hematologic cancer	2.65e-05	0.000138	CcSEcCtD
Magnesium salicylate—Headache—Doxorubicin—hematologic cancer	2.63e-05	0.000137	CcSEcCtD
Magnesium salicylate—Nausea—Doxorubicin—hematologic cancer	2.5e-05	0.00013	CcSEcCtD
Magnesium salicylate—PTGS2—Disease—DKK1—hematologic cancer	1.8e-05	0.000276	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.79e-05	0.000276	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—NUP98—hematologic cancer	1.78e-05	0.000274	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—STAT5B—hematologic cancer	1.78e-05	0.000274	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ABCG2—hematologic cancer	1.78e-05	0.000273	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—MTR—hematologic cancer	1.78e-05	0.000273	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—FHL2—hematologic cancer	1.77e-05	0.000272	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—IDH1—hematologic cancer	1.75e-05	0.000269	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.75e-05	0.000269	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CST3—hematologic cancer	1.74e-05	0.000268	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ENO2—hematologic cancer	1.74e-05	0.000268	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—AGRN—hematologic cancer	1.74e-05	0.000267	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.73e-05	0.000267	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ADCY7—hematologic cancer	1.73e-05	0.000266	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTO1—hematologic cancer	1.73e-05	0.000266	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—TXN—hematologic cancer	1.73e-05	0.000266	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ABCC3—hematologic cancer	1.73e-05	0.000266	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—IL2—hematologic cancer	1.73e-05	0.000266	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—NUP214—hematologic cancer	1.72e-05	0.000264	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—HGF—hematologic cancer	1.7e-05	0.000262	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—SPHK1—hematologic cancer	1.69e-05	0.00026	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSTT1—hematologic cancer	1.69e-05	0.00026	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—CSF2—hematologic cancer	1.68e-05	0.000259	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MTR—hematologic cancer	1.68e-05	0.000259	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—XIAP—hematologic cancer	1.68e-05	0.000259	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.66e-05	0.000256	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—SDC1—hematologic cancer	1.65e-05	0.000254	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ENO2—hematologic cancer	1.65e-05	0.000254	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—IDH2—hematologic cancer	1.65e-05	0.000253	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—HMMR—hematologic cancer	1.65e-05	0.000253	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—SMARCA4—hematologic cancer	1.64e-05	0.000252	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PRKCG—hematologic cancer	1.63e-05	0.00025	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—JAK1—hematologic cancer	1.63e-05	0.00025	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—UGT1A1—hematologic cancer	1.63e-05	0.00025	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.59e-05	0.000245	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—SLC22A1—hematologic cancer	1.58e-05	0.000243	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CRABP1—hematologic cancer	1.58e-05	0.000243	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.58e-05	0.000243	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—SDC1—hematologic cancer	1.56e-05	0.000241	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.56e-05	0.00024	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.55e-05	0.000239	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ARNTL—hematologic cancer	1.55e-05	0.000238	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ALOX5—hematologic cancer	1.54e-05	0.000237	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.54e-05	0.000237	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.52e-05	0.000234	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IL2RA—hematologic cancer	1.52e-05	0.000234	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—LCK—hematologic cancer	1.52e-05	0.000233	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—SRC—hematologic cancer	1.51e-05	0.000232	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CA9—hematologic cancer	1.5e-05	0.000232	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ACP5—hematologic cancer	1.5e-05	0.000232	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—NUP98—hematologic cancer	1.49e-05	0.00023	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.49e-05	0.000229	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—H3F3A—hematologic cancer	1.49e-05	0.000229	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—NCOR2—hematologic cancer	1.48e-05	0.000229	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	1.47e-05	0.000226	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PDGFB—hematologic cancer	1.47e-05	0.000226	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ADCY7—hematologic cancer	1.45e-05	0.000223	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—NCOA3—hematologic cancer	1.45e-05	0.000223	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PRKCZ—hematologic cancer	1.44e-05	0.000222	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—NUP214—hematologic cancer	1.44e-05	0.000221	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.42e-05	0.000219	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—CDK2—hematologic cancer	1.42e-05	0.000219	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CALR—hematologic cancer	1.42e-05	0.000218	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—IDH1—hematologic cancer	1.41e-05	0.000218	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—MTR—hematologic cancer	1.41e-05	0.000217	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ABCG2—hematologic cancer	1.41e-05	0.000217	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CD44—hematologic cancer	1.4e-05	0.000216	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—NQO1—hematologic cancer	1.4e-05	0.000216	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—TXN—hematologic cancer	1.4e-05	0.000215	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ABCC3—hematologic cancer	1.4e-05	0.000215	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTO1—hematologic cancer	1.4e-05	0.000215	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PARP1—hematologic cancer	1.39e-05	0.000215	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	1.39e-05	0.000214	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ENO2—hematologic cancer	1.38e-05	0.000213	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.37e-05	0.000212	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—FBXW7—hematologic cancer	1.37e-05	0.000211	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SPHK1—hematologic cancer	1.37e-05	0.000211	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—MAPK14—hematologic cancer	1.36e-05	0.00021	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	1.35e-05	0.000207	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HDAC2—hematologic cancer	1.35e-05	0.000207	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CXCR4—hematologic cancer	1.35e-05	0.000207	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTT1—hematologic cancer	1.34e-05	0.000206	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CD44—hematologic cancer	1.33e-05	0.000205	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYCS—hematologic cancer	1.33e-05	0.000204	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—FN1—hematologic cancer	1.32e-05	0.000204	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.32e-05	0.000203	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—HSP90AA1—hematologic cancer	1.32e-05	0.000203	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—UGT1A1—hematologic cancer	1.32e-05	0.000202	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CBL—hematologic cancer	1.31e-05	0.000202	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—SDC1—hematologic cancer	1.31e-05	0.000202	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.3e-05	0.0002	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SLC22A1—hematologic cancer	1.28e-05	0.000197	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CRABP1—hematologic cancer	1.28e-05	0.000197	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CG—hematologic cancer	1.27e-05	0.000195	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.25e-05	0.000193	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HSP90AA1—hematologic cancer	1.25e-05	0.000193	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ALOX5—hematologic cancer	1.25e-05	0.000192	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PTPN11—hematologic cancer	1.24e-05	0.000191	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.24e-05	0.00019	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—NUP98—hematologic cancer	1.21e-05	0.000186	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—STAT1—hematologic cancer	1.21e-05	0.000186	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.19e-05	0.000183	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.18e-05	0.000182	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—CREBBP—hematologic cancer	1.17e-05	0.000181	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ADCY7—hematologic cancer	1.17e-05	0.00018	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—NCOA3—hematologic cancer	1.17e-05	0.00018	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSTP1—hematologic cancer	1.17e-05	0.00018	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—NUP214—hematologic cancer	1.16e-05	0.000179	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.15e-05	0.000177	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	1.15e-05	0.000177	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—MTR—hematologic cancer	1.14e-05	0.000176	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ABCG2—hematologic cancer	1.14e-05	0.000176	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.13e-05	0.000174	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—GRB2—hematologic cancer	1.13e-05	0.000174	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PDGFA—hematologic cancer	1.13e-05	0.000173	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ENO2—hematologic cancer	1.12e-05	0.000172	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—NQO1—hematologic cancer	1.11e-05	0.000172	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CD44—hematologic cancer	1.11e-05	0.000172	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CD—hematologic cancer	1.11e-05	0.000171	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—KITLG—hematologic cancer	1.11e-05	0.000171	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ABCB1—hematologic cancer	1.11e-05	0.000171	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.09e-05	0.000168	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTT1—hematologic cancer	1.08e-05	0.000167	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—STAT5A—hematologic cancer	1.08e-05	0.000167	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSTM1—hematologic cancer	1.08e-05	0.000166	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—NCOR1—hematologic cancer	1.08e-05	0.000166	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CDKN2B—hematologic cancer	1.07e-05	0.000165	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.07e-05	0.000164	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SDC1—hematologic cancer	1.06e-05	0.000163	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYCS—hematologic cancer	1.05e-05	0.000162	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3R1—hematologic cancer	1.05e-05	0.000162	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—HSP90AA1—hematologic cancer	1.05e-05	0.000161	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CD86—hematologic cancer	1.04e-05	0.00016	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HES1—hematologic cancer	1.03e-05	0.000158	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—JAK2—hematologic cancer	1.02e-05	0.000157	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—NCOR1—hematologic cancer	1.02e-05	0.000157	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.02e-05	0.000156	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.01e-05	0.000156	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—FGF1—hematologic cancer	1.01e-05	0.000155	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—FOXO1—hematologic cancer	9.94e-06	0.000153	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PDGFRB—hematologic cancer	9.92e-06	0.000153	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PDGFRA—hematologic cancer	9.76e-06	0.00015	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—JAK1—hematologic cancer	9.73e-06	0.00015	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PRKCG—hematologic cancer	9.73e-06	0.00015	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CB—hematologic cancer	9.69e-06	0.000149	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	9.56e-06	0.000147	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—MTHFR—hematologic cancer	9.51e-06	0.000146	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	9.43e-06	0.000145	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	9.37e-06	0.000144	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTP1—hematologic cancer	9.29e-06	0.000143	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CD44—hematologic cancer	9.01e-06	0.000139	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—NQO1—hematologic cancer	9.01e-06	0.000139	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MTHFR—hematologic cancer	9.01e-06	0.000139	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	8.99e-06	0.000138	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TERT—hematologic cancer	8.99e-06	0.000138	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HLA-A—hematologic cancer	8.99e-06	0.000138	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IL2—hematologic cancer	8.9e-06	0.000137	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	8.83e-06	0.000136	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ABCB1—hematologic cancer	8.8e-06	0.000135	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PDGFB—hematologic cancer	8.77e-06	0.000135	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TSC2—hematologic cancer	8.57e-06	0.000132	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTM1—hematologic cancer	8.54e-06	0.000131	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—NCOR1—hematologic cancer	8.54e-06	0.000131	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYCS—hematologic cancer	8.53e-06	0.000131	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—HSP90AA1—hematologic cancer	8.47e-06	0.00013	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	8.38e-06	0.000129	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—FGFR3—hematologic cancer	8.25e-06	0.000127	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—EP300—hematologic cancer	7.99e-06	0.000123	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CG—hematologic cancer	7.99e-06	0.000123	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—BAD—hematologic cancer	7.82e-06	0.00012	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—SRC—hematologic cancer	7.77e-06	0.00012	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—NOTCH1—hematologic cancer	7.74e-06	0.000119	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.63e-06	0.000117	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CD80—hematologic cancer	7.58e-06	0.000117	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—KIT—hematologic cancer	7.57e-06	0.000117	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—VEGFA—hematologic cancer	7.57e-06	0.000116	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—MTHFR—hematologic cancer	7.55e-06	0.000116	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTP1—hematologic cancer	7.52e-06	0.000116	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—NRAS—hematologic cancer	7.47e-06	0.000115	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PTPN11—hematologic cancer	7.44e-06	0.000115	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CREBBP—hematologic cancer	7.41e-06	0.000114	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.27e-06	0.000112	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CREB1—hematologic cancer	7.21e-06	0.000111	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—MAPK3—hematologic cancer	7.16e-06	0.00011	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—BRAF—hematologic cancer	7.12e-06	0.00011	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ABCB1—hematologic cancer	7.12e-06	0.00011	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—IL6R—hematologic cancer	7.03e-06	0.000108	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CD—hematologic cancer	7.02e-06	0.000108	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CREBBP—hematologic cancer	7.02e-06	0.000108	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—TGFB1—hematologic cancer	6.94e-06	0.000107	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ALB—hematologic cancer	6.93e-06	0.000107	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—NCOR1—hematologic cancer	6.91e-06	0.000106	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTM1—hematologic cancer	6.91e-06	0.000106	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MAP2K1—hematologic cancer	6.7e-06	0.000103	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PIK3CD—hematologic cancer	6.66e-06	0.000102	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.65e-06	0.000102	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3R1—hematologic cancer	6.63e-06	0.000102	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—KRAS—hematologic cancer	6.43e-06	9.9e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—FGF2—hematologic cancer	6.37e-06	9.81e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CG—hematologic cancer	6.34e-06	9.76e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PIK3R1—hematologic cancer	6.28e-06	9.68e-05	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CB—hematologic cancer	6.12e-06	9.42e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—JAK2—hematologic cancer	6.11e-06	9.4e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—MTHFR—hematologic cancer	6.11e-06	9.4e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MDM2—hematologic cancer	5.96e-06	9.18e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CA—hematologic cancer	5.91e-06	9.1e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CREBBP—hematologic cancer	5.88e-06	9.05e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PIK3CB—hematologic cancer	5.8e-06	8.93e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MTOR—hematologic cancer	5.8e-06	8.93e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CD4—hematologic cancer	5.79e-06	8.91e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—TP53—hematologic cancer	5.72e-06	8.8e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CD—hematologic cancer	5.57e-06	8.58e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ALB—hematologic cancer	5.5e-06	8.47e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—HRAS—hematologic cancer	5.47e-06	8.42e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CDKN1B—hematologic cancer	5.44e-06	8.38e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.38e-06	8.28e-05	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PTEN—hematologic cancer	5.29e-06	8.14e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3R1—hematologic cancer	5.26e-06	8.1e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CG—hematologic cancer	5.13e-06	7.9e-05	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—EP300—hematologic cancer	5.04e-06	7.76e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CDKN1A—hematologic cancer	5.02e-06	7.73e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PTEN—hematologic cancer	5.01e-06	7.72e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CB—hematologic cancer	4.86e-06	7.48e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—AKT1—hematologic cancer	4.83e-06	7.43e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—EP300—hematologic cancer	4.78e-06	7.36e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CREBBP—hematologic cancer	4.76e-06	7.32e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—SRC—hematologic cancer	4.65e-06	7.16e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CD—hematologic cancer	4.51e-06	6.94e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—STAT3—hematologic cancer	4.48e-06	6.9e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—NRAS—hematologic cancer	4.47e-06	6.89e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MAPK3—hematologic cancer	4.28e-06	6.59e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3R1—hematologic cancer	4.26e-06	6.56e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PTEN—hematologic cancer	4.2e-06	6.46e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MYC—hematologic cancer	4.17e-06	6.41e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TGFB1—hematologic cancer	4.16e-06	6.4e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—EP300—hematologic cancer	4e-06	6.16e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CB—hematologic cancer	3.93e-06	6.05e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—KRAS—hematologic cancer	3.85e-06	5.93e-05	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CA—hematologic cancer	3.73e-06	5.74e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PIK3CA—hematologic cancer	3.54e-06	5.44e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PTEN—hematologic cancer	3.4e-06	5.23e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HRAS—hematologic cancer	3.27e-06	5.04e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—EP300—hematologic cancer	3.24e-06	4.99e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—IL6—hematologic cancer	3.13e-06	4.82e-05	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—AKT1—hematologic cancer	3.05e-06	4.69e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CA—hematologic cancer	2.96e-06	4.56e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—AKT1—hematologic cancer	2.89e-06	4.45e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—AKT1—hematologic cancer	2.42e-06	3.72e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CA—hematologic cancer	2.4e-06	3.69e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—AKT1—hematologic cancer	1.96e-06	3.01e-05	CbGpPWpGaD
